Source:http://linkedlifedata.com/resource/pubmed/id/15046450
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-3-29
|
pubmed:abstractText |
We have compared the concentrations of stromal-cell-derived factor-1 (SDF-1), matrix metalloproteinase-1 (MMP-1), MMP-9 and MMP-13 in serum before and after synovectomy or total knee replacement (TKR). We confirmed the presence of SDF-1 and its receptor CXCR4 in the synovium and articular cartilage by immunohistochemistry. We established chondrocytes by using mutant CXCR4 to block the release of MMPs. The level of SDF-1 was decreased 5.1- and 6.7-fold in the serum of patients with OA and RA respectively, after synovectomy compared with that before surgery. MMP-9 and MMP-13 were decreased in patients with OA and RA after synovectomy. We detected SDF-1 in the synovium and the bone marrow but not in cartilage. CXCR4 was detected in articular cartilage. SDF-1 increased the release of MMP-9 and MMP-13 from chondrocytes in a dose-dependent manner. The mutant CXCR4 blocked the release of MMP-9 and MMP-13 from chondrocytes by retrovirus vector. Synovectomy is effective in patients with OA or RA because SDF-1, which can regulate the release of MMP-9 and MMP-13 from articular chondrocytes for breakdown of cartilage, is removed by the operation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CXCL12 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CXCL12,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, CXC,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CXCR4
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0301-620X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
86
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
296-300
|
pubmed:dateRevised |
2010-11-10
|
pubmed:meshHeading |
pubmed-meshheading:15046450-Aged,
pubmed-meshheading:15046450-Aged, 80 and over,
pubmed-meshheading:15046450-Arthritis, Rheumatoid,
pubmed-meshheading:15046450-Bone Marrow,
pubmed-meshheading:15046450-Cartilage, Articular,
pubmed-meshheading:15046450-Cartilage Diseases,
pubmed-meshheading:15046450-Chemokine CXCL12,
pubmed-meshheading:15046450-Chemokines, CXC,
pubmed-meshheading:15046450-Chondrocytes,
pubmed-meshheading:15046450-Humans,
pubmed-meshheading:15046450-Immunohistochemistry,
pubmed-meshheading:15046450-Matrix Metalloproteinases,
pubmed-meshheading:15046450-Middle Aged,
pubmed-meshheading:15046450-Osteoarthritis, Knee,
pubmed-meshheading:15046450-Receptors, CXCR4,
pubmed-meshheading:15046450-Serum,
pubmed-meshheading:15046450-Synovial Membrane
|
pubmed:year |
2004
|
pubmed:articleTitle |
Synovectomy reduces stromal-cell-derived factor-1 (SDF-1) which is involved in the destruction of cartilage in osteoarthritis and rheumatoid arthritis.
|
pubmed:affiliation |
Department of Orthopaedic Surgery, Tokyo Women's Medical University, Daini Hospital, Japan.
|
pubmed:publicationType |
Journal Article
|